Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Inhibition, Psychological × itacitinib × 90 days × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Neoplasm Metastasis 1 Lymphoma, Large B-Cell, Diffuse 1 Lung Neoplasms 1 Inhibition, Psychological 1 Carcinoma, Non-Small-Cell Lung 1

Interventions

tazemetostat 1 osimertinib 1 itacitinib 1 Radiotherapy 1 INCB039110 1 AZD1390 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02917993 2026-02-09

An Open-Label Phase 1/2 Study of Itacitinib in Combination With Osimertinib in Subjects With Non-Small Cell Lung Cancer

Incyte Corporation

Phase 1/2 Completed

Carcinoma, Non-Small-Cell Lung, Inhibition, Psychological, Lung Neoplasms, Neoplasm Metastasis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡